论文部分内容阅读
米非司酮为受体水平抗孕激素,与孕酮竞争受体而达到拮抗孕酮的作用,起着抗着床、终止早孕、诱导月经及促进宫颈成熟的功效。现将本所运用米非司酮配伍米索抗早早孕300例临床效果浅析如下。 1 临床资料 1.1 资料来源:1993年10月～1996年10月本所共运用米非司酮配伍米索抗旱早孕300例,使用对象为35岁以下妇女,孕49天以内,均行B超确诊为宫内妊娠而妊娠囊小于3cm。实验室查:血常规、出凝血时间、血小板均无异常。X线查:无宫内节育器。使用上
Mifepristone as the receptor level of anti-progesterone, and progesterone competition receptor antagonistic progesterone, anti-implantation, termination of early pregnancy, induced menstruation and promote cervical maturation effect. Now by the use of mifepristone misoprostol 300 cases of early pregnancy clinical results are as follows. 1 Clinical data 1.1 Source: October 1993 ~ October 1996 a total of 300 copies of mifepristone with misoprostol early pregnancy contraception, the object for women under 35 years of age, within 49 days of pregnancy, were diagnosed with B- For intrauterine pregnancy and gestational sac is less than 3cm. Laboratory investigation: blood, a clotting time, no abnormal platelets. X-ray examination: no IUD. Use on